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Abstract
Aim: The aim of this study was to screen the suspected samples by polymerase chain reaction (PCR) and epidemiological 
analysis of positive cases of canine parvovirus type2.
Materials and Methods: Fecal samples were collected from dogs suspected for canine parvovirus type 2 (CPV-2) and viral 
DNA was extracted. Primers were designed, and PCR was done with all extracted DNA samples. Age, sex and breed wise 
distribution of positive cases were analyzed.
Results: Out of a total 44 collected fecal samples, 23 were found to be positive for CPV-2 by developed PCR. The disease 
was found to be more common in Labrador male pups of 3-6 months of age. The percentage of positive cases in vaccinated 
dogs was found to be around 17.4%.
Conclusion: Almost half (52.3%) of total collected samples were found to be positive by PCR. However, number of field 
samples are needed to further validate this test and additionally sequence analysis needs to be done to ensure the prevalent 
field strain of CPV-2.
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Introduction
Canine parvovirus type 2 (CPV-2) is a non-envel-
oped single-stranded DNA virus which is responsible 
for an acute and sometimes fatal enteritis in dogs [1]. 
It accounts for up to 26% of the mortality among all 
viral diseases of dogs [2]. The virus first appeared 
in 1978, probably arose from a very closely related 
virus in cats, the feline panleukopenia virus through 
a small number of mutations in the single capsid pro-
tein. Then, it has spread worldwide and being replaced 
by some new antigenic variants likes CPV-2a, CPV-2b 
and CPV-2c [3]. Currently, this is one of the important 
pathogenic viruses affecting dogs with high morbidity 
and mortality [4].
Parvoviral disease of dogs is mainly manifested 
as two forms, intestinal and myocardial form. Intestinal 
form is more common which is characterized by hem-
orrhagic gastroenteritis, and the less common myocar-
dial form is characterized by myocarditis [5]. Several 
molecular and serological techniques are available for 
the detection of viral antigens and antibodies to the 
virus [5]. Vaccination is the most efficient strategy for 
the control of the disease.
The present study was undertaken with an objec-
tive to determine the epidemiology of CPV-2 infec-
tion by polymerase chain reaction (PCR) in Bareilly 
region.
Materials and Methods
Ethical approval 
Not necessary as fecal samples were collected 
from clinical cases.
Sample collection
A total of 44 fecal samples were collected from 
dogs suspected of CPV-2 infection showing typical 
clinical signs such as foul smelling, hemorrhagic diar-
rhea and vomiting presented at Veterinary Polyclinic, 
Indian Veterinary Research Institute during the time 
period from October 2013 to April 2014.
Extraction of DNA from the fecal sample
The DNA was extracted from all 44 fecal sam-
ples collected from dogs using QIAamp DNA Mini 
Kit (Qiagen, Germany) as per the suggested protocol.
Primer designing
Specific primers were designed for the ampli-
fication of a part of VP2 (tVP2) gene of CPV-2 by 
comparing the published sequence of CPV-2 (Gene 
bank accession number EU377537.1, GI 166153875) 
using IDT Oligoanalyzer 3.1. PCR was standardized 
using the recombinant plasmid containing VP2 gene 
(KJ364525) obtained from immunology lab, IVRI. To 
standardize the optimum annealing temperature for 
proper amplification of tVP2 gene, gradient PCR was 
also done using the same positive control with anneal-
ing temperature ranging from 52°C to 64°C (Tm of 
CPV PF is 63.1°C and CPV PR is 54.4°C).
The sequences of the forward (CPV PF) and 
reverse (CPV PR) primers are given in Table-1.
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Polymerase chain reaction
Polymerase chain reaction was performed using 
DNA extracted from fecal samples with positive con-
trol as recombinant plasmid DNA (KJ364525) and 
negative control without any template DNA. PCR 
reaction was set up in a standard 25 μl reaction con-
taining the following reagents using the standardized 
condition. The components used for PCR are given in 
Table-2. All the PCR ingredients were procured from 
Thermoscientific, USA.
PCR product was visualized using 1% agarose 
gel electrophoresis.
Analysis of positive cases
Sex, breed and age wise distribution of positive 
cases were analyzed.
Results
The PCR conditions were standardized for the 
designed primers CPV PF and CPV PR as follows:
Step 1: Initial denaturation - 95°C for 5 min.
Step 2: Denaturation - 95°C for 45 s.
Step 3: Annealing - 58°C for 45 s - 32 cycles.
Step 4: Elongation - 72°C for 1 min.
Step 5: Final elongation - 72°C for 10 min.
Out of 44 fecal isolated DNA samples, 23 were 
found to be positive by developed PCR as it revealed a 
single and uniform band of 564 bp size on 1% agarose 
gel (Figure-1). On the basis of analysis of the positive 
samples it is revealed that the disease was found to 
be more common in Labrador pups and 3-6 months 
male puppies are mostly affected. The age, sex and 
breed wise analyses of positive cases are given in 
Figures-2-4 respectively. Out of the total positive 
samples 17.4% of cases were from vaccinated dogs.
Discussion
Parvoviral disease is an economically important 
disease of domestic and wild carnivores, especially 
dogs [5] with two clinical forms-intestinal and myo-
cardial. The main clinical symptom associated with 
the intestinal form of CPV-2 affected dogs is hemor-
rhagic gastroenteritis. It is difficult to precisely diag-
nose CPV-2 infection from the main clinical signs, 
such as vomiting and diarrhea because these symp-
toms are more or less common to other enteric dis-
eases [6]. There are several methods for confirmatory 
diagnosis of parvoviral disease [7]. PCR technique is 
widely used as a tool for the diagnosis of canine par-
voviral infection which provides rapid, sensitive and 
accurate diagnosis of the disease [8]. In the present 
study, PCR was developed by designing new prim-
ers considering all the critical residues contributes to 
Table-1: Primers used for amplification of tVP2 gene.
Target gene Name of primer Sequence (5’-….-3’) Length PCR amplicon size
tVP2 gene CPV-PF ACTGCAGCGAATTCAGGTGATGAATTTGCTACAG 34 ~564 bp
CPV-PR CTGACCTCGAGAGTATAGTTAATTCC 26
PCR=Polymerase chain reaction, CPV=Canine parvovirus type 
Table-2: Polymerase chain reaction.
Component (stock) Amount
10×Taq buffer 2.5 μl
MgCl2 (1.5 mM) 1.5 μl
Forward primer, CPV-PF (10 pM/μl) 0.5 μl
Reverse primer, CPV-PR (10 pM/μl) 0.5 μl
dNTP mix (10mM) 0.5 μl
Taq DNA polymerase (0.5 U/μl) 0.5 μl
Nuclease free water 17.5 μl
DNA 1.5 μl
Total 25.0 μl
CPV=Canine parvovirus type
Figure-1: 1% agarose gel electrophoresis showing 564 bp 
size band from positive samples. Lane M: 100 bp plus 
ladder. Lane 1-6: Positive samples.
Figure-2: Sex wise analysis of positive samples.
strain differences so that every variant of CPV-2 can 
be detected. Primers were designed by considering the 
facts like absence of dimerization capability, absence 
of significant hairpin formation and lack of secondary 
priming sites in the template. Melting temperature and 
GC content (CPV PF - 44.1%, CPV PR - 42.3%) of 
the primers were in the normal range. Optimization Available at www.veterinaryworld.org/Vol.7/November-2014/5.pdf
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of annealing temperature was done by gradient PCR. 
The optimal annealing temperature depends upon the 
melting temperature of the primer-template hybrid. 
High annealing temperature result in the inefficient 
primer annealing, but very low annealing temperature 
may lead to a non-specific annealing. In the present 
study, a fairly good amplification of a specific prod-
uct could be observed at an annealing temperature of 
58°C corresponding to 564 bp size on 1% agarose gel. 
Thus, annealing temperature of developed PCR was 
optimized as 58°C.
PCR results indicated that 52.3% of dogs clin-
ically showing the typical disease symptoms were 
found to be positive for CPV-2. The present find-
ing revealed that the disease was more common 
in Labrador breed which is in contrary to the pre-
vious reports that German shepherd, Rottweiler 
and Doberman are more susceptible to CPV-2 [9]. 
However, in the current study most of dogs (around 
39%) admitted in the hospital were Labrador pup-
pies compared to other breeds like German shepherd, 
Rottweiler and Doberman. This may be the reason for 
relatively high percentage of positive cases observed 
in Labrador dogs. Younger dogs are generally pro-
tected from CPV-2 infection by maternally-derived 
immunity [5]. Susceptibility to CPV-2 infection often 
coincides with the time that puppies are separated from 
dams as the level of protective immunity, or maternal 
immunity declined [3]. In the current study, 62.51% 
of the cases were from 3 to 6 months aged puppies 
parallel to previous reports. In addition, it is found 
that disease was mainly observed in male dogs and 
reason may be due to the fact that more than 65% of 
admitted dogs were male. Even though, there is no sex 
prelidiction for canine parvovirus disease, it is specu-
lated that males usually travel more than female and 
then they are more susceptible to field challenge [10]. 
There was no any biasness in the collection of samples 
in respect to breed, sex and age.
In parallel to the previous reports of vaccination 
failure [11], 17.4% of infected dogs in the current 
study were vaccinated against CPV-2. PCR positivity 
in recently vaccinated dogs may be due to the contin-
uous excretion of the vaccine strain through feces up 
to 2-3 weeks following vaccination. However, there 
are many reasons for failure of vaccination. There are 
many reports that dogs may suffer from parvoviral 
enteritis even after practicing all the recommended 
guidelines of immunization [11]. One of the principal 
reasons behind the failure of vaccination is the per-
sistence of interfering levels of maternal antibodies. 
The successful vaccination can only be achieved when 
maternal antibody levels decline to less than or equal 
to 1:10 [12]. Another cause of vaccination failure is 
the poor vaccine efficacy. There are some concerns 
that whether the CPV-2 based vaccines are effective 
against new antigenic variants [13]. In India, most 
of the vaccines marketed are based on the original 
CPV-2 isolated about 30 years ago. However, CPV-2a 
and 2b has recently outpaced the original CPV-2 inci-
dence in dogs in most parts of the world [14] includ-
ing India [15]. Hence, sequence analysis of CPV-2 
isolates may throw some light on reasons behind vac-
cination failure.
Conclusion
PCR is a sensitive technique for diagnosing the 
paroviral disease. In the present study, 52.3% sus-
pected cases were confirmed to be positive by PCR. 
Disease reported in vaccinated animals suggests that 
further studies are needed to explain the reasons 
behind vaccination failure. The emergence of new 
strains makes the vaccine efficacy questionable. So 
research studies should be focused on this aspect for 
the effective control, early diagnosis and proper treat-
ment of the disease.
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